Non-invasive ventilatory support in the management of respiratory failure after autologous peripheral blood stem cell transplantation
Rabitsch et al 1 recently described the successful use of high-flow CPAP (continuous positive air pressure) ventilation via a sealed face mask in the treatment of bacterial pneumonia developing in a patient with Hodgkin's lymphoma after autologous peripheral blood progenitor cell rescue (aPBPCT). We used the same non-invasive ventilatory support in a 20-year-old woman with Hodgkin's disease who had undergone high-dose therapy and aPBPCT. On day ϩ5 she developed fever (39°C) and broad spectrum antibiotic therapy (imipenem, ceftriaxone, teicoplanin and vancomycin) was started. ANC at day ϩ5 was 0.02 ϫ 10 9 /l. Chest X-ray was negative. Fever persisted and amphotericin B was empirically added and G-CSF 5 g/kg/day was started. On day ϩ8 the patient developed dyspnea and decreased arterial oxygen saturation measured by pulse oximetry (76% without oxygen supplementation). Chest X-ray showed bilateral mild interstitial and alveolar abnormalities predominantly at the lung bases. The ANC was 0.34 ϫ 10 9 /l and the G-CSF was discontinued. Her respiratory status worsened dramatically over 48 h. With a fraction of inspired oxygen (FiO 2 ) of 0.5 via a non-sealed face-mask, the PaO 2 was 52 mmHg, PaCO 2 21.9 mmHg and pH 7.5 on day ϩ9. High-flow CPAP ventilation via a sealed face mask was initiated in an attempt to avoid intubation. Chest X-ray showed bilateral patchy alveolar infiltrates and bilateral pleural effusion. High-dose immunoglobulins, prednisone, diuretics and low-dose dopamine were added. FiO 2 of 0.8 and a positive end expiratory pressure (PEEP) of 10 mbar was delivered with an improvement in oxygenation (PaO 2 149, PaCo 2 32.8, pH 7.38). FiO 2 was reduced to 0.6 with a CPAP of 10 mbar and maintained for 5 days. The fever finally subsided and an improvement in respiratory function was noticed. FiO 2 was reduced gradually to 0.3 with a CPAP of 7 mbar. On day 21 the patient was changed to intermittent CPAP and oxygen supplementation via a non-sealing face mask. Chest X-ray documented a reduction of bilateral alveolar infiltrates and resolution of the pleural effusions. She was discharged on day ϩ39 and she is alive and well 33 months after autoPBPCT.
CPAP is an effective non-invasive ventilatory support measure which can be easily instituted. Use of CPAP also allows delay of endotracheal intubation or may even be a substitute for this. We agree with the authors 1 regarding patient compliance with CPAP which is of paramount importance and which requires patient cooperation. In our case CPAP was extremely well tolerated for a prolonged period (18 days) with progressive weaning from oxygen therapy. CPAP permits patients with respiratory failure to be managed in BMT units but requires well trained nurses and physicians with knowledge of the potential complications of non-invasive ventilatory support.
In conclusion, institution of CPAP, as well as other methods of non-invasive ventilatory support should be pursued in appropriate BMT patients with respiratory failure after they have been fully evaluated.
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